CSF1R and plasma cell myeloma: In myeloma, colony stimulating factor 1 receptor (CSF-1R) expressing tumor associated macrophages (TAM) have been shown to promote disease progression and CSF-1R inhibition prolongs myeloma-specific immunity, particularly after ASCT (29, 31, 76).